JP2004507501A - ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用 - Google Patents
ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用 Download PDFInfo
- Publication number
- JP2004507501A JP2004507501A JP2002522888A JP2002522888A JP2004507501A JP 2004507501 A JP2004507501 A JP 2004507501A JP 2002522888 A JP2002522888 A JP 2002522888A JP 2002522888 A JP2002522888 A JP 2002522888A JP 2004507501 A JP2004507501 A JP 2004507501A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- branched
- phenylmethoxy
- methylene
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940121375 antifungal agent Drugs 0.000 title claims description 15
- 239000003429 antifungal agent Substances 0.000 title claims description 11
- SGIZECXZFLAGBW-UHFFFAOYSA-N 5-benzylidene-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1=CC1=CC=CC=C1 SGIZECXZFLAGBW-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 59
- 239000001257 hydrogen Substances 0.000 claims abstract description 53
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 24
- 125000001424 substituent group Chemical group 0.000 claims abstract description 24
- 150000003839 salts Chemical class 0.000 claims abstract description 16
- 206010017533 Fungal infection Diseases 0.000 claims abstract description 12
- 208000031888 Mycoses Diseases 0.000 claims abstract description 12
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 8
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 8
- 101100516572 Caenorhabditis elegans nhr-8 gene Proteins 0.000 claims abstract description 5
- 150000002431 hydrogen Chemical class 0.000 claims abstract 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 128
- 150000001875 compounds Chemical class 0.000 claims description 102
- 125000000217 alkyl group Chemical group 0.000 claims description 91
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 89
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 77
- 238000000034 method Methods 0.000 claims description 74
- -1 phenylmethoxy Chemical group 0.000 claims description 72
- 125000005975 2-phenylethyloxy group Chemical group 0.000 claims description 48
- 125000003118 aryl group Chemical group 0.000 claims description 34
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 27
- 125000004076 pyridyl group Chemical group 0.000 claims description 20
- 125000002541 furyl group Chemical group 0.000 claims description 18
- 125000001544 thienyl group Chemical group 0.000 claims description 18
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical group C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 13
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 208000015181 infectious disease Diseases 0.000 claims description 11
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 7
- 239000005695 Ammonium acetate Substances 0.000 claims description 7
- 229940043376 ammonium acetate Drugs 0.000 claims description 7
- 235000019257 ammonium acetate Nutrition 0.000 claims description 7
- 125000003386 piperidinyl group Chemical group 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- MQCZHTDGFLSFOD-UHFFFAOYSA-N 2-[4-oxo-5-[[4-(2-phenylethoxy)-3-phenylmethoxyphenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCCC1=CC=CC=C1 MQCZHTDGFLSFOD-UHFFFAOYSA-N 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 6
- 101100533877 Hypocrea jecorina (strain QM6a) sor8 gene Proteins 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 5
- MFCHSBDIWCBMFE-LJQANCHMSA-N 2-[4-oxo-5-[[3-phenylmethoxy-4-[(2s)-2-phenylpropoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C([C@@H](C)C=1C=CC=CC=1)OC(C(=C1)OCC=2C=CC=CC=2)=CC=C1C=C1SC(=S)N(CC(O)=O)C1=O MFCHSBDIWCBMFE-LJQANCHMSA-N 0.000 claims description 4
- QBKDSAYHKBXKQL-UHFFFAOYSA-N 2-[4-oxo-5-[[3-phenylmethoxy-4-[[4-(trifluoromethoxy)phenyl]methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=C(OC(F)(F)F)C=C1 QBKDSAYHKBXKQL-UHFFFAOYSA-N 0.000 claims description 4
- KWYBOLDSAURJIK-UHFFFAOYSA-N 2-[4-oxo-5-[[3-phenylmethoxy-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=C(C(F)(F)F)C=C1 KWYBOLDSAURJIK-UHFFFAOYSA-N 0.000 claims description 4
- LHYRKNFTTKMDNQ-DWXRJYCRSA-N 2-[4-oxo-5-[[4-[(2s)-2-phenylpropoxy]-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C([C@@H](C)C=1C=CC=CC=1)OC(C(=C1)O[C@@H](C=2C=CC=CC=2)C(F)(F)F)=CC=C1C=C1SC(=S)N(CC(O)=O)C1=O LHYRKNFTTKMDNQ-DWXRJYCRSA-N 0.000 claims description 4
- XTFYPIJXZLFEAR-UHFFFAOYSA-N 2-[5-[[3,4-bis[(2,4-difluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C(=CC(F)=CC=2)F)=CC=C1OCC1=CC=C(F)C=C1F XTFYPIJXZLFEAR-UHFFFAOYSA-N 0.000 claims description 4
- XGNWOQWQTFJAQN-UHFFFAOYSA-N 2-[5-[[3,4-bis[(4-fluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC(F)=CC=2)=CC=C1OCC1=CC=C(F)C=C1 XGNWOQWQTFJAQN-UHFFFAOYSA-N 0.000 claims description 4
- JDVBNGAJBKGNLT-UHFFFAOYSA-N 2-[5-[[3-[(3,4-difluorophenyl)methoxy]-4-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=C(F)C(F)=CC=2)=CC=C1OCC1=CC=CC=C1 JDVBNGAJBKGNLT-UHFFFAOYSA-N 0.000 claims description 4
- RYINIELRRQTSQL-UHFFFAOYSA-N 2-[5-[[4-(2-cyclohexylethoxy)-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCCC1CCCCC1 RYINIELRRQTSQL-UHFFFAOYSA-N 0.000 claims description 4
- SSKLGZLYOABIDO-UHFFFAOYSA-N 2-[5-[[4-[2-(4-chlorophenyl)ethoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCCC1=CC=C(Cl)C=C1 SSKLGZLYOABIDO-UHFFFAOYSA-N 0.000 claims description 4
- FXPLNNDKZYARSZ-UHFFFAOYSA-N 2-[5-[[4-[2-(4-fluorophenyl)ethoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCCC1=CC=C(F)C=C1 FXPLNNDKZYARSZ-UHFFFAOYSA-N 0.000 claims description 4
- YNOGAFPQUMNNHQ-UHFFFAOYSA-N 2-[5-[[4-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 YNOGAFPQUMNNHQ-UHFFFAOYSA-N 0.000 claims description 4
- 241001480037 Microsporum Species 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- YAHWWUNPHNZBOT-UHFFFAOYSA-N 2-[4-oxo-5-[[4-(2,2,3,3,3-pentafluoropropoxy)-3-phenylmethoxyphenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC1=CC=C(OCC(F)(F)C(F)(F)F)C(OCC=2C=CC=CC=2)=C1 YAHWWUNPHNZBOT-UHFFFAOYSA-N 0.000 claims description 3
- LHYRKNFTTKMDNQ-QYBDOPJKSA-N 2-[4-oxo-5-[[4-[(2r)-2-phenylpropoxy]-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C([C@H](C)C=1C=CC=CC=1)OC(C(=C1)O[C@@H](C=2C=CC=CC=2)C(F)(F)F)=CC=C1C=C1SC(=S)N(CC(O)=O)C1=O LHYRKNFTTKMDNQ-QYBDOPJKSA-N 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 241000223238 Trichophyton Species 0.000 claims description 3
- 150000003935 benzaldehydes Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- KOYJKQFGCGIFEU-UHFFFAOYSA-N 2-[4-oxo-5-[[3-(phenoxymethyl)-4-phenylmethoxyphenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1COC=2C=CC=CC=2)=CC=C1OCC1=CC=CC=C1 KOYJKQFGCGIFEU-UHFFFAOYSA-N 0.000 claims description 2
- GIHSGMSTRANTBM-UHFFFAOYSA-N 2-[4-oxo-5-[[3-phenylmethoxy-4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=CC(C(F)(F)F)=C1 GIHSGMSTRANTBM-UHFFFAOYSA-N 0.000 claims description 2
- AOAROSLFYLNGCD-UHFFFAOYSA-N 2-[4-oxo-5-[[4-(2-phenylethoxy)-3-(2,2,2-trifluoro-1-phenylethoxy)phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OC(C=2C=CC=CC=2)C(F)(F)F)=CC=C1OCCC1=CC=CC=C1 AOAROSLFYLNGCD-UHFFFAOYSA-N 0.000 claims description 2
- IUBJVPOPUFQYOQ-UHFFFAOYSA-N 2-[5-[[3-[2-(dibutylamino)-2-oxo-1-phenylethoxy]-4-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C=1C=CC=CC=1C(C(=O)N(CCCC)CCCC)OC(C(=CC=1)OCC=2C=CC=CC=2)=CC=1C=C1SC(=S)N(CC(O)=O)C1=O IUBJVPOPUFQYOQ-UHFFFAOYSA-N 0.000 claims description 2
- ICNYEXXENSBATD-UHFFFAOYSA-N 2-[5-[[4-[(3,4-difluorophenyl)methoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=C(F)C(F)=C1 ICNYEXXENSBATD-UHFFFAOYSA-N 0.000 claims description 2
- OWSLGYWEPUDVAT-UHFFFAOYSA-N 2-[5-[[4-[(4-chlorophenyl)methoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C=C1 OWSLGYWEPUDVAT-UHFFFAOYSA-N 0.000 claims description 2
- 241000228197 Aspergillus flavus Species 0.000 claims description 2
- 241001225321 Aspergillus fumigatus Species 0.000 claims description 2
- 229940091771 aspergillus fumigatus Drugs 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 101100495911 Arabidopsis thaliana CHR10 gene Proteins 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- FFYJVTLTZYPAAB-UQQQWYQISA-N 5-[[3-(1-phenylethoxy)-4-(2-phenylethoxy)phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic acid Chemical compound C=1C=CC=CC=1C(C)OC(C(=CC=1)OCCC=2C=CC=CC=2)=CC=1\C=C1/SC(=S)N(CC(O)=O)C1=O FFYJVTLTZYPAAB-UQQQWYQISA-N 0.000 claims 1
- 201000007336 Cryptococcosis Diseases 0.000 claims 1
- 241000221204 Cryptococcus neoformans Species 0.000 claims 1
- 238000005815 base catalysis Methods 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 285
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 219
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 180
- 239000000047 product Substances 0.000 description 73
- 239000000843 powder Substances 0.000 description 65
- 239000000243 solution Substances 0.000 description 64
- 239000003208 petroleum Substances 0.000 description 62
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 61
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 60
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 55
- 238000005160 1H NMR spectroscopy Methods 0.000 description 52
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 239000011541 reaction mixture Substances 0.000 description 35
- 238000005481 NMR spectroscopy Methods 0.000 description 34
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 34
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 32
- 229910052938 sodium sulfate Inorganic materials 0.000 description 32
- 235000011152 sodium sulphate Nutrition 0.000 description 32
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 27
- 239000012267 brine Substances 0.000 description 26
- 239000000741 silica gel Substances 0.000 description 26
- 229910002027 silica gel Inorganic materials 0.000 description 26
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 26
- QEBZGDYGMMSNRY-UHFFFAOYSA-N 2-phenoxy-2-phenylacetamide Chemical compound C=1C=CC=CC=1C(C(=O)N)OC1=CC=CC=C1 QEBZGDYGMMSNRY-UHFFFAOYSA-N 0.000 description 25
- 239000007787 solid Substances 0.000 description 22
- 238000004587 chromatography analysis Methods 0.000 description 21
- 239000008194 pharmaceutical composition Substances 0.000 description 20
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 20
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 18
- 229910000024 caesium carbonate Inorganic materials 0.000 description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 238000010828 elution Methods 0.000 description 14
- 239000003921 oil Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- ABUKMOCUMIPDHV-UHFFFAOYSA-N 2-phenoxy-2-phenylacetic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)OC1=CC=CC=C1 ABUKMOCUMIPDHV-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 239000012044 organic layer Substances 0.000 description 10
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000003480 eluent Substances 0.000 description 9
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 8
- 0 CS(OCc1cc(C=O)ccc1OCc1ccccc1)(=*)=O Chemical compound CS(OCc1cc(C=O)ccc1OCc1ccccc1)(=*)=O 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 239000012230 colorless oil Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241000222122 Candida albicans Species 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229940095731 candida albicans Drugs 0.000 description 7
- 210000002421 cell wall Anatomy 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 230000002538 fungal effect Effects 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 7
- OAOJBMHAQUUUTE-UHFFFAOYSA-N 3-hydroxy-4-(2-phenylethoxy)benzaldehyde Chemical compound OC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 OAOJBMHAQUUUTE-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 238000004293 19F NMR spectroscopy Methods 0.000 description 5
- OOENNZREZDKUHB-UHFFFAOYSA-N 2-[5-[[3,4-bis(phenylmethoxy)phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=CC=C1 OOENNZREZDKUHB-UHFFFAOYSA-N 0.000 description 5
- CWMRCRFALIQFHU-UHFFFAOYSA-N 4-hydroxy-3-phenylmethoxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 CWMRCRFALIQFHU-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HZQDBFJELNYTKE-UHFFFAOYSA-N (5-formyl-2-phenylmethoxyphenyl)methyl methanesulfonate Chemical compound CS(=O)(=O)OCC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 HZQDBFJELNYTKE-UHFFFAOYSA-N 0.000 description 4
- JGRMXPSUZIYDRR-UHFFFAOYSA-N 2-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetic acid Chemical compound OC(=O)CN1C(=O)CSC1=S JGRMXPSUZIYDRR-UHFFFAOYSA-N 0.000 description 4
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 description 4
- DVFRQYJNNUBERX-UHFFFAOYSA-N 3-(phenoxymethyl)-4-phenylmethoxybenzaldehyde Chemical compound C=1C=CC=CC=1OCC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 DVFRQYJNNUBERX-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102100024023 Histone PARylation factor 1 Human genes 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000010626 work up procedure Methods 0.000 description 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 3
- WHBNKGILKCASDH-UHFFFAOYSA-N 2-(2,4-dioxo-1,3-thiazolidin-3-yl)acetic acid Chemical compound OC(=O)CN1C(=O)CSC1=O WHBNKGILKCASDH-UHFFFAOYSA-N 0.000 description 3
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 3
- DGGBSOBIYGYECX-UHFFFAOYSA-N 2-[4-oxo-2-sulfanylidene-5-[[3,4,5-tris(phenylmethoxy)phenyl]methylidene]-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC(OCC=2C=CC=CC=2)=C1OCC1=CC=CC=C1 DGGBSOBIYGYECX-UHFFFAOYSA-N 0.000 description 3
- UOUYKRHRZOBMCO-UHFFFAOYSA-N 2-[4-oxo-5-[(4-pentoxy-3-phenylmethoxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C1=C(OCC=2C=CC=CC=2)C(OCCCCC)=CC=C1C=C1SC(=S)N(CC(O)=O)C1=O UOUYKRHRZOBMCO-UHFFFAOYSA-N 0.000 description 3
- UNLOPKZKGWMHGD-UHFFFAOYSA-N 2-[5-[1-(3-methoxy-4-phenylmethoxyphenyl)ethylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound COC1=CC(C(C)=C2C(N(CC(O)=O)C(=S)S2)=O)=CC=C1OCC1=CC=CC=C1 UNLOPKZKGWMHGD-UHFFFAOYSA-N 0.000 description 3
- BHVBBVSEXONYKM-UHFFFAOYSA-N 2-[5-[[3,4-bis[(4-methoxyphenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C1=CC(OC)=CC=C1COC(C(=C1)OCC=2C=CC(OC)=CC=2)=CC=C1C=C1C(=O)N(CC(O)=O)C(=S)S1 BHVBBVSEXONYKM-UHFFFAOYSA-N 0.000 description 3
- ZBURNDZUTYZCKH-UHFFFAOYSA-N 2-[5-[[4-[(2,4-difluorophenyl)methoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=C(F)C=C1F ZBURNDZUTYZCKH-UHFFFAOYSA-N 0.000 description 3
- YVQIGHAEGQBJBB-UHFFFAOYSA-N 2-[5-[[4-[(4-methylphenyl)methoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C1=CC(C)=CC=C1COC(C(=C1)OCC=2C=CC=CC=2)=CC=C1C=C1C(=O)N(CC(O)=O)C(=S)S1 YVQIGHAEGQBJBB-UHFFFAOYSA-N 0.000 description 3
- CCIQRGLWXGAUEB-UHFFFAOYSA-N 3-(1-phenylethoxy)-4-(2-phenylethoxy)benzaldehyde Chemical compound C=1C=CC=CC=1C(C)OC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 CCIQRGLWXGAUEB-UHFFFAOYSA-N 0.000 description 3
- FYNGPYHJLQRZEH-UHFFFAOYSA-N 3-(hydroxymethyl)-4-(2-phenylethoxy)benzaldehyde Chemical compound OCC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 FYNGPYHJLQRZEH-UHFFFAOYSA-N 0.000 description 3
- WPEUHXUMNIBPKH-UHFFFAOYSA-N 3-(phenoxymethyl)-4-(2-phenylethoxy)benzaldehyde Chemical compound C=1C=CC=CC=1OCC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 WPEUHXUMNIBPKH-UHFFFAOYSA-N 0.000 description 3
- GJEDLJSDEZYRQT-UHFFFAOYSA-N 3-hydroxy-4-[(4-methoxyphenyl)methoxy]benzaldehyde Chemical compound C1=CC(OC)=CC=C1COC1=CC=C(C=O)C=C1O GJEDLJSDEZYRQT-UHFFFAOYSA-N 0.000 description 3
- HUNGEAFDVLSPAM-UHFFFAOYSA-N 3-hydroxy-4-phenylmethoxybenzaldehyde Chemical compound OC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 HUNGEAFDVLSPAM-UHFFFAOYSA-N 0.000 description 3
- VLWDESUHXBSPDI-GOSISDBHSA-N 3-phenylmethoxy-4-[(2s)-2-phenylpropoxy]benzaldehyde Chemical compound C([C@@H](C)C=1C=CC=CC=1)OC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 VLWDESUHXBSPDI-GOSISDBHSA-N 0.000 description 3
- QEICZEGWCSHJNS-UHFFFAOYSA-N 3-phenylmethoxy-4-[[4-(trifluoromethyl)phenyl]methoxy]benzaldehyde Chemical compound C1=CC(C(F)(F)F)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 QEICZEGWCSHJNS-UHFFFAOYSA-N 0.000 description 3
- OKFUIDSZUWWIGG-UHFFFAOYSA-N 4-(2,2,3,3,3-pentafluoropropoxy)-3-phenylmethoxybenzaldehyde Chemical compound FC(F)(F)C(F)(F)COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 OKFUIDSZUWWIGG-UHFFFAOYSA-N 0.000 description 3
- LTBMVIUURINDRI-UHFFFAOYSA-N 4-(2-cyclohexylethoxy)-3-phenylmethoxybenzaldehyde Chemical compound C=1C=CC=CC=1COC1=CC(C=O)=CC=C1OCCC1CCCCC1 LTBMVIUURINDRI-UHFFFAOYSA-N 0.000 description 3
- HYIMLCBUZXLKNR-UHFFFAOYSA-N 4-(2-phenylethoxy)-3-(2,2,2-trifluoro-1-phenylethoxy)benzaldehyde Chemical compound C=1C=CC=CC=1C(C(F)(F)F)OC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 HYIMLCBUZXLKNR-UHFFFAOYSA-N 0.000 description 3
- NXKDHOLJDMFZSJ-UHFFFAOYSA-N 4-(2-phenylethoxy)-3-(pyridin-2-ylmethoxy)benzaldehyde Chemical compound C=1C=CC=NC=1COC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 NXKDHOLJDMFZSJ-UHFFFAOYSA-N 0.000 description 3
- AYWMXTFLDCNODY-QFIPXVFZSA-N 4-[(4-methoxyphenyl)methoxy]-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]benzaldehyde Chemical compound C1=CC(OC)=CC=C1COC1=CC=C(C=O)C=C1O[C@H](C(F)(F)F)C1=CC=CC=C1 AYWMXTFLDCNODY-QFIPXVFZSA-N 0.000 description 3
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- 101150065749 Churc1 gene Proteins 0.000 description 3
- 241000223203 Coccidioides Species 0.000 description 3
- 241001480035 Epidermophyton Species 0.000 description 3
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 3
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 206010065764 Mucosal infection Diseases 0.000 description 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 3
- 102100038239 Protein Churchill Human genes 0.000 description 3
- IIMJORKPQQXZHC-UHFFFAOYSA-N [5-formyl-2-(2-phenylethoxy)phenyl]methyl methanesulfonate Chemical compound CS(=O)(=O)OCC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 IIMJORKPQQXZHC-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000011200 topical administration Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- FPIRBHDGWMWJEP-UHFFFAOYSA-N 1-hydroxy-7-azabenzotriazole Chemical compound C1=CN=C2N(O)N=NC2=C1 FPIRBHDGWMWJEP-UHFFFAOYSA-N 0.000 description 2
- 125000005976 1-phenylethyloxy group Chemical group 0.000 description 2
- DQEAQMVSHGBDMM-UHFFFAOYSA-N 2-[4-oxo-5-[[3-phenylmethoxy-4-(pyridin-2-ylmethoxy)phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=CC=N1 DQEAQMVSHGBDMM-UHFFFAOYSA-N 0.000 description 2
- STQKCXNXIQARBH-UHFFFAOYSA-N 2-[4-oxo-5-[[4-(2-phenylethoxy)-3-(pyridin-2-ylmethoxy)phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid hydrochloride Chemical compound Cl.O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2N=CC=CC=2)=CC=C1OCCC1=CC=CC=C1 STQKCXNXIQARBH-UHFFFAOYSA-N 0.000 description 2
- AOAROSLFYLNGCD-RUZDIDTESA-N 2-[4-oxo-5-[[4-(2-phenylethoxy)-3-[(1r)-2,2,2-trifluoro-1-phenylethoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1O[C@H](C=2C=CC=CC=2)C(F)(F)F)=CC=C1OCCC1=CC=CC=C1 AOAROSLFYLNGCD-RUZDIDTESA-N 0.000 description 2
- AOAROSLFYLNGCD-VWLOTQADSA-N 2-[4-oxo-5-[[4-(2-phenylethoxy)-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1O[C@@H](C=2C=CC=CC=2)C(F)(F)F)=CC=C1OCCC1=CC=CC=C1 AOAROSLFYLNGCD-VWLOTQADSA-N 0.000 description 2
- RGELCJSIYQXBQJ-UHFFFAOYSA-N 2-[4-oxo-5-[[4-phenylmethoxy-3-(pyridin-2-ylmethoxy)phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=S)SC1=CC(C=C1OCC=2N=CC=CC=2)=CC=C1OCC1=CC=CC=C1 RGELCJSIYQXBQJ-UHFFFAOYSA-N 0.000 description 2
- XPEVTLJZABKDHG-UHFFFAOYSA-N 2-[5-[(4-methoxy-3-phenylmethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C1=C(OCC=2C=CC=CC=2)C(OC)=CC=C1C=C1SC(=S)N(CC(O)=O)C1=O XPEVTLJZABKDHG-UHFFFAOYSA-N 0.000 description 2
- YWTZXQOVHMLSGN-UHFFFAOYSA-N 2-[5-[[3,4-bis(phenylmethoxy)phenyl]methylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]acetic acid Chemical compound O=C1N(CC(=O)O)C(=O)SC1=CC(C=C1OCC=2C=CC=CC=2)=CC=C1OCC1=CC=CC=C1 YWTZXQOVHMLSGN-UHFFFAOYSA-N 0.000 description 2
- HNTNFSGQGSEFGM-UHFFFAOYSA-N 2-[5-[[3-[(4-methylsulfonylphenyl)methoxy]-4-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1COC1=CC(C=C2C(N(CC(O)=O)C(=S)S2)=O)=CC=C1OCC1=CC=CC=C1 HNTNFSGQGSEFGM-UHFFFAOYSA-N 0.000 description 2
- KXXVXDYWAYXDTO-UHFFFAOYSA-N 2-[5-[[4-[(4-methylsulfonylphenyl)methoxy]-3-phenylmethoxyphenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1COC(C(=C1)OCC=2C=CC=CC=2)=CC=C1C=C1C(=O)N(CC(O)=O)C(=S)S1 KXXVXDYWAYXDTO-UHFFFAOYSA-N 0.000 description 2
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- CUQKDYHGMOYBRE-UHFFFAOYSA-N 3-hydroxy-4-pentoxybenzaldehyde Chemical compound CCCCCOC1=CC=C(C=O)C=C1O CUQKDYHGMOYBRE-UHFFFAOYSA-N 0.000 description 2
- MXZSPCLJEUPSHP-UHFFFAOYSA-N 3-phenylmethoxy-4-(pyridin-2-ylmethoxy)benzaldehyde Chemical compound C=1C=CC=CC=1COC1=CC(C=O)=CC=C1OCC1=CC=CC=N1 MXZSPCLJEUPSHP-UHFFFAOYSA-N 0.000 description 2
- FKDUDJQJJLXANY-UHFFFAOYSA-N 3-phenylmethoxy-4-[[4-(trifluoromethoxy)phenyl]methoxy]benzaldehyde Chemical compound C1=CC(OC(F)(F)F)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 FKDUDJQJJLXANY-UHFFFAOYSA-N 0.000 description 2
- HYIMLCBUZXLKNR-JOCHJYFZSA-N 4-(2-phenylethoxy)-3-[(1r)-2,2,2-trifluoro-1-phenylethoxy]benzaldehyde Chemical compound O([C@@H](C(F)(F)F)C=1C=CC=CC=1)C1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 HYIMLCBUZXLKNR-JOCHJYFZSA-N 0.000 description 2
- QYAQPWFKNCNYAC-SBUREZEXSA-N 4-[(2r)-2-phenylpropoxy]-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]benzaldehyde Chemical compound C1([C@H](OC2=CC(C=O)=CC=C2OC[C@H](C)C=2C=CC=CC=2)C(F)(F)F)=CC=CC=C1 QYAQPWFKNCNYAC-SBUREZEXSA-N 0.000 description 2
- QYAQPWFKNCNYAC-HXOBKFHXSA-N 4-[(2s)-2-phenylpropoxy]-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]benzaldehyde Chemical compound C1([C@H](OC2=CC(C=O)=CC=C2OC[C@@H](C)C=2C=CC=CC=2)C(F)(F)F)=CC=CC=C1 QYAQPWFKNCNYAC-HXOBKFHXSA-N 0.000 description 2
- PPFIKTPBIVSEHJ-UHFFFAOYSA-N 4-[(4-chlorophenyl)methoxy]-3-phenylmethoxybenzaldehyde Chemical compound C1=CC(Cl)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 PPFIKTPBIVSEHJ-UHFFFAOYSA-N 0.000 description 2
- LHGZGZHGOPGTBK-UHFFFAOYSA-N 4-[(4-methylphenyl)methoxy]-3-phenylmethoxybenzaldehyde Chemical compound C1=CC(C)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 LHGZGZHGOPGTBK-UHFFFAOYSA-N 0.000 description 2
- AAHYBQDGJJEWKD-AWEZNQCLSA-N 4-hydroxy-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]benzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O[C@H](C(F)(F)F)C1=CC=CC=C1 AAHYBQDGJJEWKD-AWEZNQCLSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 108010049047 Echinocandins Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000400611 Eucalyptus deanei Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101001047783 Homo sapiens Histone PARylation factor 1 Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 102000006722 Mannosyltransferases Human genes 0.000 description 2
- 108010087568 Mannosyltransferases Proteins 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 101001123538 Nicotiana tabacum Putrescine N-methyltransferase 1 Proteins 0.000 description 2
- 101100241858 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OAC1 gene Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 2
- GBXZONVFWYCRPT-KVTDHHQDSA-N [(2s,3s,4r,5r)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] dihydrogen phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](C=O)OP(O)(O)=O GBXZONVFWYCRPT-KVTDHHQDSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001336 alkenes Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000009109 curative therapy Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 150000002031 dolichols Chemical class 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 108010005335 mannoproteins Proteins 0.000 description 2
- 238000005621 mannosylation reaction Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- NHFBYYMNJUMVOT-UHFFFAOYSA-N methyl 2-bromo-2-phenylacetate Chemical compound COC(=O)C(Br)C1=CC=CC=C1 NHFBYYMNJUMVOT-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- XSXHWVKGUXMUQE-UHFFFAOYSA-N osmium dioxide Inorganic materials O=[Os]=O XSXHWVKGUXMUQE-UHFFFAOYSA-N 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 125000000109 phenylethoxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])O* 0.000 description 2
- 101150092906 pmt1 gene Proteins 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- GQHFCGULTKNUQX-UHFFFAOYSA-N (2,2,2-trifluoro-1-phenylethyl) trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC(C(F)(F)F)C1=CC=CC=C1 GQHFCGULTKNUQX-UHFFFAOYSA-N 0.000 description 1
- NPZZVZUWMKFFPF-UHFFFAOYSA-N (2-bromo-2-phenylethyl) acetate Chemical compound CC(=O)OCC(Br)C1=CC=CC=C1 NPZZVZUWMKFFPF-UHFFFAOYSA-N 0.000 description 1
- LDDMACCNBZAMSG-BDVNFPICSA-N (2r,3r,4s,5r)-3,4,5,6-tetrahydroxy-2-(methylamino)hexanal Chemical compound CN[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO LDDMACCNBZAMSG-BDVNFPICSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- CRRUGYDDEMGVDY-UHFFFAOYSA-N 1-bromoethylbenzene Chemical compound CC(Br)C1=CC=CC=C1 CRRUGYDDEMGVDY-UHFFFAOYSA-N 0.000 description 1
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
- PSQZJKGXDGNDFP-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropan-1-ol Chemical compound OCC(F)(F)C(F)(F)F PSQZJKGXDGNDFP-UHFFFAOYSA-N 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- KPWPXZKNQFZFMF-UHFFFAOYSA-N 2-(4,5-dioxo-2-sulfanylidene-1,3-thiazolidin-3-yl)acetic acid Chemical compound OC(=O)CN1C(=S)SC(=O)C1=O KPWPXZKNQFZFMF-UHFFFAOYSA-N 0.000 description 1
- NJWIMFZLESWFIM-UHFFFAOYSA-N 2-(chloromethyl)pyridine Chemical compound ClCC1=CC=CC=N1 NJWIMFZLESWFIM-UHFFFAOYSA-N 0.000 description 1
- QEZYNSXJLFISBS-UHFFFAOYSA-N 2-methoxy-3-phenylmethoxybenzaldehyde Chemical compound C1=CC=C(C=O)C(OC)=C1OCC1=CC=CC=C1 QEZYNSXJLFISBS-UHFFFAOYSA-N 0.000 description 1
- FTZQGKNKPLTWCJ-UHFFFAOYSA-N 2-methoxy-4-(4-methylsulfonylphenyl)-3-phenylmethoxybenzaldehyde Chemical compound COc1c(C=O)ccc(c1OCc1ccccc1)-c1ccc(cc1)S(C)(=O)=O FTZQGKNKPLTWCJ-UHFFFAOYSA-N 0.000 description 1
- AOPRXJXHLWYPQR-UHFFFAOYSA-N 2-phenoxyacetamide Chemical compound NC(=O)COC1=CC=CC=C1 AOPRXJXHLWYPQR-UHFFFAOYSA-N 0.000 description 1
- ABEPSQZVZNRXCY-UHFFFAOYSA-N 3,4,5-tris(phenylmethoxy)benzaldehyde Chemical compound C=1C=CC=CC=1COC=1C(OCC=2C=CC=CC=2)=CC(C=O)=CC=1OCC1=CC=CC=C1 ABEPSQZVZNRXCY-UHFFFAOYSA-N 0.000 description 1
- XDDLXZHBWVFPRG-UHFFFAOYSA-N 3,4-bis(phenylmethoxy)benzaldehyde Chemical compound C=1C=CC=CC=1COC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 XDDLXZHBWVFPRG-UHFFFAOYSA-N 0.000 description 1
- SXMNWKBBBYQNGR-UHFFFAOYSA-N 3,4-bis[(4-fluorophenyl)methoxy]benzaldehyde Chemical compound C1=CC(F)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=C(F)C=C1 SXMNWKBBBYQNGR-UHFFFAOYSA-N 0.000 description 1
- DXDYEQZZACUTLH-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-2-methoxy-4-phenylmethoxybenzaldehyde Chemical compound COc1c(C=O)ccc(OCc2ccccc2)c1-c1ccc(F)c(F)c1 DXDYEQZZACUTLH-UHFFFAOYSA-N 0.000 description 1
- OYTAYRZFBZUFGJ-UHFFFAOYSA-N 3-(hydroxymethyl)-4-phenylmethoxybenzaldehyde Chemical compound OCC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 OYTAYRZFBZUFGJ-UHFFFAOYSA-N 0.000 description 1
- JGATWZJHQQIGPY-UHFFFAOYSA-N 3-[(3,4-difluorophenyl)methoxy]-4-phenylmethoxybenzaldehyde Chemical compound C1=C(F)C(F)=CC=C1COC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 JGATWZJHQQIGPY-UHFFFAOYSA-N 0.000 description 1
- QCLOBUFKSPFPBH-UHFFFAOYSA-N 3-[(4-methylsulfonylphenyl)methoxy]-4-phenylmethoxybenzaldehyde Chemical compound C1=CC(S(=O)(=O)C)=CC=C1COC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 QCLOBUFKSPFPBH-UHFFFAOYSA-N 0.000 description 1
- KAXYYFIFTLUGSH-UHFFFAOYSA-N 3-phenylmethoxy-4-[[3-(trifluoromethyl)phenyl]methoxy]benzaldehyde Chemical compound FC(F)(F)C1=CC=CC(COC=2C(=CC(C=O)=CC=2)OCC=2C=CC=CC=2)=C1 KAXYYFIFTLUGSH-UHFFFAOYSA-N 0.000 description 1
- UJCPKOIVAVYZMS-UHFFFAOYSA-N 4-(2,4-difluorophenyl)-2-methoxy-3-phenylmethoxybenzaldehyde Chemical compound COc1c(C=O)ccc(c1OCc1ccccc1)-c1ccc(F)cc1F UJCPKOIVAVYZMS-UHFFFAOYSA-N 0.000 description 1
- HYIMLCBUZXLKNR-QFIPXVFZSA-N 4-(2-phenylethoxy)-3-[(1s)-2,2,2-trifluoro-1-phenylethoxy]benzaldehyde Chemical compound O([C@H](C(F)(F)F)C=1C=CC=CC=1)C1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 HYIMLCBUZXLKNR-QFIPXVFZSA-N 0.000 description 1
- GOUIRIFORVFVOM-UHFFFAOYSA-N 4-(2-phenylethoxy)-3-phenylmethoxybenzaldehyde Chemical compound C=1C=CC=CC=1COC1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 GOUIRIFORVFVOM-UHFFFAOYSA-N 0.000 description 1
- NWWORWIYBLAYJD-UHFFFAOYSA-N 4-(2-phenylethoxy)benzaldehyde Chemical compound C1=CC(C=O)=CC=C1OCCC1=CC=CC=C1 NWWORWIYBLAYJD-UHFFFAOYSA-N 0.000 description 1
- UJEQNYBFMWNLMX-UHFFFAOYSA-N 4-(3,4-difluorophenyl)-2-methoxy-3-phenylmethoxybenzaldehyde Chemical compound COc1c(C=O)ccc(c1OCc1ccccc1)-c1ccc(F)c(F)c1 UJEQNYBFMWNLMX-UHFFFAOYSA-N 0.000 description 1
- VTNHRLBVGYEVLY-UHFFFAOYSA-N 4-[(2,4-difluorophenyl)methoxy]-3-phenylmethoxybenzaldehyde Chemical compound FC1=CC(F)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 VTNHRLBVGYEVLY-UHFFFAOYSA-N 0.000 description 1
- WQYMEDKSQCOCRN-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)methoxy]-3-phenylmethoxybenzaldehyde Chemical compound C1=C(F)C(F)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 WQYMEDKSQCOCRN-UHFFFAOYSA-N 0.000 description 1
- IOTRGNBQFDQYQI-UHFFFAOYSA-N 4-[(4-methoxyphenyl)methoxy]-3-phenylmethoxybenzaldehyde Chemical compound C1=CC(OC)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 IOTRGNBQFDQYQI-UHFFFAOYSA-N 0.000 description 1
- MOWYGCXTUPPVEQ-UHFFFAOYSA-N 4-[(4-methylsulfonylphenyl)methoxy]-3-phenylmethoxybenzaldehyde Chemical compound C1=CC(S(=O)(=O)C)=CC=C1COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 MOWYGCXTUPPVEQ-UHFFFAOYSA-N 0.000 description 1
- KREKFFLJMWUKSD-UHFFFAOYSA-N 4-[2-(4-fluorophenyl)ethoxy]-3-phenylmethoxybenzaldehyde Chemical compound C1=CC(F)=CC=C1CCOC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 KREKFFLJMWUKSD-UHFFFAOYSA-N 0.000 description 1
- OCTRLIRIVJADGZ-UHFFFAOYSA-N 4-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-3-phenylmethoxybenzaldehyde Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(COC=2C(=CC(C=O)=CC=2)OCC=2C=CC=CC=2)=C1 OCTRLIRIVJADGZ-UHFFFAOYSA-N 0.000 description 1
- SCXZNYRQOPBUTM-UHFFFAOYSA-N 4-hydroxy-3-(hydroxymethyl)benzaldehyde Chemical compound OCC1=CC(C=O)=CC=C1O SCXZNYRQOPBUTM-UHFFFAOYSA-N 0.000 description 1
- VQVQZFHUXRSRBZ-UHFFFAOYSA-N 4-methoxy-3-phenylmethoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 VQVQZFHUXRSRBZ-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- BIYJKFUIXZMNQV-UHFFFAOYSA-N 4-pentoxy-3-phenylmethoxybenzaldehyde Chemical compound CCCCCOC1=CC=C(C=O)C=C1OCC1=CC=CC=C1 BIYJKFUIXZMNQV-UHFFFAOYSA-N 0.000 description 1
- XNQNPLQYHSGQDQ-UHFFFAOYSA-N 4-phenylmethoxy-3-(pyridin-2-ylmethoxy)benzaldehyde Chemical compound C=1C=CC=NC=1COC1=CC(C=O)=CC=C1OCC1=CC=CC=C1 XNQNPLQYHSGQDQ-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010060968 Arthritis infective Diseases 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- XBECSRJJNREIBI-UHFFFAOYSA-N C=[O]CC(C1=CCCC=C1)Oc(cc(C=O)cc1)c1OCCc1ccccc1 Chemical compound C=[O]CC(C1=CCCC=C1)Oc(cc(C=O)cc1)c1OCCc1ccccc1 XBECSRJJNREIBI-UHFFFAOYSA-N 0.000 description 1
- HKUNFPHBXNAHRQ-UHFFFAOYSA-N CCCC(C(C(c1ccccc1)OC(C(CC1)OCCc2ccccc2)C=C1C=O)=O)SCCC Chemical compound CCCC(C(C(c1ccccc1)OC(C(CC1)OCCc2ccccc2)C=C1C=O)=O)SCCC HKUNFPHBXNAHRQ-UHFFFAOYSA-N 0.000 description 1
- MUZULNZSILKEIG-XYGWBWBKSA-N CCCCCOc1ccc(/C=C(/C(N(CC(O)=O)C2=S)=O)\S2=C)cc1C1C(Cc2ccccc2)C1 Chemical compound CCCCCOc1ccc(/C=C(/C(N(CC(O)=O)C2=S)=O)\S2=C)cc1C1C(Cc2ccccc2)C1 MUZULNZSILKEIG-XYGWBWBKSA-N 0.000 description 1
- 101001123543 Caenorhabditis elegans Phosphoethanolamine N-methyltransferase 1 Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OSKAAGJVZKTSJT-UHFFFAOYSA-N OC(C(c1ccccc1)Oc(cc(C=O)cc1)c1OCCc1ccccc1)=O Chemical compound OC(C(c1ccccc1)Oc(cc(C=O)cc1)c1OCCc1ccccc1)=O OSKAAGJVZKTSJT-UHFFFAOYSA-N 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical class C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- CALQKRVFTWDYDG-UHFFFAOYSA-N butan-1-amine;hydroiodide Chemical compound [I-].CCCC[NH3+] CALQKRVFTWDYDG-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007775 late Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- AMYIBYTXYMGLMV-QRPNPIFTSA-N methane (2R)-2-phenylpropane-1-sulfonic acid Chemical compound C1(=CC=CC=C1)[C@H](CS(=O)(=O)O)C.C AMYIBYTXYMGLMV-QRPNPIFTSA-N 0.000 description 1
- AMYIBYTXYMGLMV-DDWIOCJRSA-N methane (2S)-2-phenylpropane-1-sulfonic acid Chemical compound C1(=CC=CC=C1)[C@@H](CS(=O)(=O)O)C.C AMYIBYTXYMGLMV-DDWIOCJRSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- WWJFFVUVFNBJTN-UHFFFAOYSA-N neopolyoxin C Natural products C=1C=C(O)C=NC=1C(O)C(C)C(N)C(=O)NC(C(O)=O)C(C(C1O)O)OC1N1C=CC(=O)NC1=O WWJFFVUVFNBJTN-UHFFFAOYSA-N 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- WWJFFVUVFNBJTN-VHDFTHOZSA-N nikkomycin Z Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)[C@H](NC(=O)[C@@H](N)[C@H](C)[C@H](O)C=2N=CC(O)=CC=2)C(O)=O)C=CC(=O)NC1=O WWJFFVUVFNBJTN-VHDFTHOZSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- ZMRHBJQLCDZMAH-UHFFFAOYSA-M sodium chloride hydrate hydrochloride Chemical compound [OH-].[Na+].Cl.Cl ZMRHBJQLCDZMAH-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003239 susceptibility assay Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003548 thiazolidines Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0021421.3A GB0021421D0 (en) | 2000-08-31 | 2000-08-31 | Compounds |
| PCT/GB2001/003862 WO2002017915A1 (en) | 2000-08-31 | 2001-08-30 | Benzylidene thiazolidinediones and their use as antimycotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004507501A true JP2004507501A (ja) | 2004-03-11 |
| JP2004507501A5 JP2004507501A5 (cg-RX-API-DMAC7.html) | 2005-04-14 |
Family
ID=9898616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002522888A Pending JP2004507501A (ja) | 2000-08-31 | 2001-08-30 | ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7105554B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1313471B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004507501A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE359073T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2001284190A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60127845T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2282283T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0021421D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002017915A1 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011520968A (ja) * | 2008-05-20 | 2011-07-21 | メルク・シャープ・エンド・ドーム・コーポレイション | マンノシルトランスフェラーゼ阻害剤を使用した異種蛋白質の効率的生産 |
| WO2014024897A1 (ja) * | 2012-08-06 | 2014-02-13 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | チアゾリジンジオンおよびピロリジンジオン誘導体、並びにそれらを有効成分としてなる殺菌剤 |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0204252D0 (en) * | 2002-02-23 | 2002-04-10 | Oxford Glycosciences Uk Ltd | Novel compounds |
| WO2003070238A1 (en) * | 2002-02-23 | 2003-08-28 | Oxford Glycosciences (Uk) Ltd | Thiazolidine antifungal agents |
| AP2315A (en) | 2004-03-23 | 2011-11-04 | Pfizer | Formamide derivatives useful as adrenoceptor. |
| ES2534465T3 (es) | 2005-11-15 | 2015-04-23 | Glycofi, Inc. | Producción de glucoproteínas con O-glucosilación reducida |
| US7731106B2 (en) * | 2006-01-04 | 2010-06-08 | Nano Mist International, Llc | Air driven delivery system for sprayable media |
| US8637435B2 (en) * | 2007-11-16 | 2014-01-28 | Merck Sharp & Dohme Corp. | Eukaryotic cell display systems |
| CA2715212A1 (en) * | 2008-03-03 | 2009-09-11 | Glycofi, Inc. | Surface display of recombinant proteins in lower eukaryotes |
| US8067339B2 (en) | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
| CN102177247A (zh) | 2008-08-12 | 2011-09-07 | 格利科菲公司 | 用于蛋白生产: ca2+ atp酶过表达的改良的载体和酵母菌株 |
| US8936918B2 (en) | 2011-02-25 | 2015-01-20 | Merck Sharp & Dohme Corp. | Yeast strain for the production of proteins with modified O-glycosylation |
| ES2563232T3 (es) * | 2011-07-29 | 2016-03-11 | Taisho Pharmaceutical Co., Ltd. | Compuesto de amidina o sal del mismo |
| WO2014062811A2 (en) * | 2012-10-16 | 2014-04-24 | New York University | METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2 |
| CN105492457A (zh) | 2013-07-04 | 2016-04-13 | 诺华股份有限公司 | O-甘露糖基转移酶缺陷的丝状真菌细胞及其使用方法 |
| WO2016012468A1 (en) | 2014-07-21 | 2016-01-28 | Novartis Ag | Production of glycoproteins with mammalian-like n-glycans in filamentous fungi |
| JP2019523229A (ja) * | 2016-06-14 | 2019-08-22 | ヴェルシテック リミテッド | 抗微生物化合物及びその使用方法 |
| CN109476656A (zh) * | 2016-06-24 | 2019-03-15 | 俄亥俄州大学 | 葡萄糖转运抑制剂及使用其的方法 |
| RU2662153C1 (ru) * | 2017-04-20 | 2018-07-24 | Общество С Ограниченной Ответственностью "Дермавитал Групп" | Гибридные эфиры на основе производных тиазолидин-2,4-диона и азолов (1н-1,3-имидазола и 1н-1,3,4-триазола) и их применение |
| RU2690161C1 (ru) * | 2018-06-28 | 2019-05-31 | Общество С Ограниченной Ответственностью "Дермавитал Групп" | 3,5-Замещенные производные тиазолидин-2,4-диона, обладающие противомикробной активностью |
| RU2703997C1 (ru) * | 2018-12-13 | 2019-10-23 | Общество с ограниченной ответственностью "Л-Био" | Гибридные амиды на основе триазола и тиазолидина, обладающие антимикробной активностью |
| CN112521382A (zh) * | 2020-12-14 | 2021-03-19 | 西南大学 | 芦荟大黄素噻唑烷二酮类化合物及其制备方法和应用 |
| WO2024258316A1 (ru) * | 2023-06-16 | 2024-12-19 | Общество с ограниченной ответственностью "Л-Био" | Новые потенциальные противогрибковые средства на основе тиазолидин-2,4-диона и триазола |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6156175A (ja) * | 1984-08-24 | 1986-03-20 | Yamanouchi Pharmaceut Co Ltd | ロダニン誘導体およびその製造法 |
| JPH06192091A (ja) * | 1992-09-10 | 1994-07-12 | Eli Lilly & Co | 血糖低下用およびアルツハイマー病治療用化合物 |
| WO1994029287A1 (de) * | 1993-06-04 | 1994-12-22 | Boehringer Mannheim Gmbh | Aryliden-4-oxo-2-thioxo-3-thiazolidincarbonsäuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JPH08109175A (ja) * | 1994-10-07 | 1996-04-30 | Torii Yakuhin Kk | チアゾリジン−２−オンエステル誘導体 |
| JPH08109174A (ja) * | 1994-10-07 | 1996-04-30 | Torii Yakuhin Kk | チアゾリジン−２−オン誘導体 |
| WO2000018747A1 (en) * | 1998-09-30 | 2000-04-06 | Roche Diagnostics Gmbh | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| WO2000018746A1 (en) * | 1998-09-30 | 2000-04-06 | Roche Diagnostics Gmbh | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders |
| WO2001057006A1 (en) * | 2000-02-03 | 2001-08-09 | F. Hoffmann-La Roche Ag | Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer |
-
2000
- 2000-08-31 GB GBGB0021421.3A patent/GB0021421D0/en not_active Ceased
-
2001
- 2001-08-30 EP EP01963157A patent/EP1313471B1/en not_active Expired - Lifetime
- 2001-08-30 ES ES01963157T patent/ES2282283T3/es not_active Expired - Lifetime
- 2001-08-30 WO PCT/GB2001/003862 patent/WO2002017915A1/en not_active Ceased
- 2001-08-30 JP JP2002522888A patent/JP2004507501A/ja active Pending
- 2001-08-30 AT AT01963157T patent/ATE359073T1/de not_active IP Right Cessation
- 2001-08-30 DE DE60127845T patent/DE60127845T2/de not_active Expired - Lifetime
- 2001-08-30 AU AU2001284190A patent/AU2001284190A1/en not_active Abandoned
-
2003
- 2003-02-21 US US10/371,964 patent/US7105554B2/en not_active Expired - Fee Related
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6156175A (ja) * | 1984-08-24 | 1986-03-20 | Yamanouchi Pharmaceut Co Ltd | ロダニン誘導体およびその製造法 |
| JPH06192091A (ja) * | 1992-09-10 | 1994-07-12 | Eli Lilly & Co | 血糖低下用およびアルツハイマー病治療用化合物 |
| WO1994029287A1 (de) * | 1993-06-04 | 1994-12-22 | Boehringer Mannheim Gmbh | Aryliden-4-oxo-2-thioxo-3-thiazolidincarbonsäuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JPH08109175A (ja) * | 1994-10-07 | 1996-04-30 | Torii Yakuhin Kk | チアゾリジン−２−オンエステル誘導体 |
| JPH08109174A (ja) * | 1994-10-07 | 1996-04-30 | Torii Yakuhin Kk | チアゾリジン−２−オン誘導体 |
| WO2000018747A1 (en) * | 1998-09-30 | 2000-04-06 | Roche Diagnostics Gmbh | Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| WO2000018746A1 (en) * | 1998-09-30 | 2000-04-06 | Roche Diagnostics Gmbh | Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders |
| WO2001057006A1 (en) * | 2000-02-03 | 2001-08-09 | F. Hoffmann-La Roche Ag | Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer |
| JP2003521542A (ja) * | 2000-02-03 | 2003-07-15 | エフ．ホフマン−ラ ロシュ アーゲー | チアゾリジンカルボン酸誘導体及び癌の治療におけるその利用 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011520968A (ja) * | 2008-05-20 | 2011-07-21 | メルク・シャープ・エンド・ドーム・コーポレイション | マンノシルトランスフェラーゼ阻害剤を使用した異種蛋白質の効率的生産 |
| WO2014024897A1 (ja) * | 2012-08-06 | 2014-02-13 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | チアゾリジンジオンおよびピロリジンジオン誘導体、並びにそれらを有効成分としてなる殺菌剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001284190A1 (en) | 2002-03-13 |
| ES2282283T3 (es) | 2007-10-16 |
| EP1313471A1 (en) | 2003-05-28 |
| DE60127845D1 (de) | 2007-05-24 |
| WO2002017915A1 (en) | 2002-03-07 |
| DE60127845T2 (de) | 2007-12-20 |
| EP1313471B1 (en) | 2007-04-11 |
| US20040006112A1 (en) | 2004-01-08 |
| US7105554B2 (en) | 2006-09-12 |
| ATE359073T1 (de) | 2007-05-15 |
| GB0021421D0 (en) | 2000-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004507501A (ja) | ベンジリデンチアゾリジンジオンおよび抗真菌剤としてのそれらの使用 | |
| ES2320320T3 (es) | Nuevos compuestos de isoxazol y tiazol y uso de los mismos como farmacos. | |
| EP1244642B1 (en) | Substituted oxazoles and thiazoles derivatives as hppar alpha activators | |
| DE69835241T2 (de) | 4-Aminothiazol Derivate, deren Herstellung und deren Verwendung als Inhibitoren Cyclin-abhängiger Kinasen | |
| Liu et al. | Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity | |
| HUT72747A (en) | Process for producing thiazolylvinylphenyl-compounds and pharmaceutical compositions containing them | |
| JP2008519083A (ja) | アミノキナゾリン化合物 | |
| CS248750B2 (en) | Production method of the 2-(n-subst.guanidino)-4-heteroarylthiazols | |
| AU2004259000A1 (en) | Design and synthesis of optimized ligands for PPAR | |
| EP1313731B1 (en) | Thiazolidine derivatives and its use as antifungal agent | |
| EP2496230B1 (en) | Ire-1 alpha inhibitors | |
| WO2003090869A1 (en) | Lxr modulators | |
| JPS6330308B2 (cg-RX-API-DMAC7.html) | ||
| SK159995A3 (en) | Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents | |
| KR102491316B1 (ko) | 노화-관련 장애 치료용 화합물 | |
| CZ20033252A3 (en) | Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor | |
| EP1590337B1 (fr) | Derives d' acylaminothiazole, leur preparation et leur utilisation en tant qu' inhibiteurs de la production du peptide beta-amyloide | |
| JP2014532656A (ja) | 炎症および免疫関連用途のための化合物 | |
| JPH0141616B2 (cg-RX-API-DMAC7.html) | ||
| DE69107874T2 (de) | Imidazolderivate und diese Imidazolderivate als Wirkstoffe enthaltende Antiepileptika. | |
| JPH06135943A (ja) | 新規なウラシル誘導体及びそれを有効成分とするアレルギー疾患治療薬 | |
| US11932609B1 (en) | Substituted 1,4-dihydropyrimidines as antitubercular agents | |
| JPH0450305B2 (cg-RX-API-DMAC7.html) | ||
| WO2003070238A1 (en) | Thiazolidine antifungal agents | |
| JP2518497B2 (ja) | 抗脂血剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080826 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110927 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120131 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120626 |